FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称OVALICIN
异名/同义词(-)-OVALICIN
(3S,4R,5S)-4-HYDROXY-5-METHOXY-4-((2S,3R)-2-METHYL-3-(3-METHYL-2-BUTEN-1-YL)-2-OXIRANYL)-1-OXASPIRO(2.5)OCTAN-6-ONE
1-OXASPIRO(2.5)OCTAN-6-ONE, 4-(1,2-EPOXY-1,5-DIMETHYL-4-HEXENYL)-4-HYDROXY-5-METHOXY-, (1S,2R,3S,4R,5S)-(-)-
1-OXASPIRO(2.5)OCTAN-6-ONE, 4-HYDROXY-5-METHOXY-4-((2S,3R)-2-METHYL-3-(3-METHYL-2-BUTEN-1-YL)-2-OXIRANYL)-, (3S,4R,5S)-
1-OXASPIRO(2.5)OCTAN-6-ONE, 4-HYDROXY-5-METHOXY-4-((2S,3R)-2-METHYL-3-(3-METHYL-2-BUTENYL)OXIRANYL)-, (3S,4R,5S)-
GRAPHINONE
OVALICIN
CAS登记号19683-98-8
物质唯一标识(Unique Ingredient Identifier)XBF6GMZ9TW
分子式C16H24O5
国际化合物标识(International Chemical Identifier,InChI)NESRXFGQJARQNM-OWYFMNJBSA-N
SMILESCO[C@@H]1C(=O)CC[C@]2(CO2)[C@@]1(O)[C@@]3(C)O[C@@H]3CC=C(C)C
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
    扩展资源
    ©2006-2024 Drugfuture->FDA Global Substance Registration System